4.5 Article

An update on the management of cholestatic liver diseases

Journal

CLINICAL MEDICINE
Volume 20, Issue 5, Pages 513-516

Publisher

ROY COLL PHYS LONDON EDITORIAL OFFICE
DOI: 10.7861/clinmed.2020-0697

Keywords

Primary biliary cholangitis; primary sclerosing cholangitis; risk stratification; ursodeoxycholic acid; cholangiocarcinoma

Ask authors/readers for more resources

Cholestatic liver diseases are a challenging spectrum of conditions arising from damage to bile ducts, leading to build-up of bile acids and inflammatory processes that cause injury to cholangiocytes and hepatocytes. Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are the two most common cholestatic disorders. In this review we detail the latest guidelines for the diagnosis and management of patients with these two conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available